Ole Magnus Fløgstad

Ole Magnus Fløgstad is a Doctoral Research Fellow in the Division of Biochemistry at the University of Oslo. His research focuses on optimizing mass spectrometry techniques to characterize the interaction between HER2 and trastuzumab, a key area in cancer therapy. He is affiliated with the Sekulic Group and is based at Domus Medica in Oslo. Contact: o.m.flogstad@ncmbm.uio.no.

Research interests include proteomics, antibody-epitope interactions, and biomedical applications of mass spectrometry. His work contributes to advancing targeted cancer treatments through detailed molecular analysis.